January 04, 2025 03:26 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
India objects to China's 'new counties' announcement, says parts of these come under Ladakh | No cause for alarm over HMPV virus spread in China: Indian Health Agency | PM Modi gives a call for change in Delhi launching fierce attack on Arvind Kejriwal's AAP | Quran open to passage glorifying violence, bomb-making materials tracked in New Orleans attacker Shamshud-Din Jabbar's home | Jasprit Bumrah leads India in series decider after Rohit Sharma opts to rest in Sydney Test amid poor show with willow | Punjab cop dismissed for facilitating TV interview of Larence Bishnoi while in custody | 'Not Veer Savarkar', Congress student wing demands Delhi college be named after Manmohan Singh | 'Cowardly': PM Modi condemns New Orleans terrorist attack that killed 15 | Prashant Kishor starts fast unto death over Bihar Public Service Commission prelims cancellation demand | Bangladesh court denies bail to arrested Hindu monk Chinmoy Krishna Das

Biocon Biologics announces major leadership changes

Aug 05, 2023, at 04:34 am

Mumbai: Biocon Biologics Ltd made leadership changes on Friday, revealing the appointments of Rhonda Duffy as Chief Operating Officer (COO) and Sandeep Athalye as Chief Development Officer.

Infosys announces Kiran Mazumdar-Shaw's retirement from board

Mar 24, 2023, at 02:17 am

Mumbai: Infosys on Thursday announced that Kiran Mazumdar-Shaw, an Independent Director, has retired from its Board upon completion of her tenure on March 22, 2023.

Kotak Special Situations Fund invests Rs 1070 cr in bio-pharma firm Biocon

Feb 23, 2023, at 06:08 am

Kolkata/IBNS: Kotak Special Situations Fund (KSSF), managed by Kotak Investment Advisors Ltd (KIAL), Wednesday announced an investment of Rs 1,070 crore in Biocon Ltd (BL), according to an official statement.

Biocon Q2FY21 revenue at Rs 1,760 cr, up 10 pc

Oct 23, 2020, at 10:42 pm

Bengaluru/UNI: Biocon Ltd, an innovation-led global biopharmaceuticals company on Friday announced its consolidated financial results for the fiscal second quarter ended September 30, 2020.

Biocon Revenue moves up by 14 pc and stood at 1690 Cr in Q1FY21

Jul 24, 2020, at 10:00 pm

Bengaluru/UNI: Pharmaceutical major Biocon Ltd, has reported revenue of Rs 1,690 Crore, an increase by 14 per cent, during the Q1 Financial year 2020-21.